Budget impact analysis of use of aliskiren in hypertension on the Italian Health Care System by Orietta Zaniolo, Lorenzo Pradelli

Subjects: Get full text

Budget impact analysis of baricitinib for treatment of alopecia areata: A Saudi hospital perspective by A. Alshahrani, S. Al-Aqeel, M. Alshahrani, S. Alqahtani, S.T. Alhawwashi, M.S. Al-Nasser, M. Zaitoun

Subjects: “…Budget impact analysis…”
Get full text

CLINICAL ECONOMIC ANALYSIS OF USING ERIBULIN (HALAVEN®) FOR TREATMENT OF PATIENTS WITH METASTATIC BREAST CANCER by S. L. Plavinsky, P. I. Shabalkin

Subjects: Get full text

Good practices for the development of budget impact models at regional level by Andrea Marcellusi, Angela Ragonese, Andrea Marinozzi, Alberto Bortolami, Sara Mucherino, Carolina Moreno, Amalia Antenori, Matteo Ferrario, Claudia Simonelli, Matteo Zanussi, Marco Cicoira, Ruggero Lasala, Francesco Russoniello, Francesco Attanasio, Caterina Donati, Chiara Roni, Fabrizio Gemmi, Francesco Saverio Mennini, Pierluigi Russo, Giovanna Scroccaro, PierLuigi Canonico

Subjects: Get full text

US Budget Impact Model for Selinexor in Relapsed or Refractory Multiple Myeloma by Bassali J, Gould IG, Kaye JA, Mladsi D, Mehta J

Subjects: “…multiple myeloma – budget impact analysis – selinexor - us…”
Get full text

Budget impact analysis of extended half-life recombinant factor IX (rFIXFc) in the treatment of haemophilia B by Andrea Aiello, Maria Elisa Mancuso, Alessio Colombo, Cristina Teruzzi, Patrizia Berto

Subjects: “…Budget impact analysis…”
Get full text

Budget impact analysis of surfactant therapy for bronchiolitis in critically ill infants: the Colombian National Health System perspective by Jefferson Antonio Buendía, Diana Guerrero Patiño

Subjects: Get full text

Budget Impact Analysis of Switching to Rituximab’s Biosimilar in Rheumatology and Cancer in 13 Countries Within the Middle East and North Africa by Almaaytah A

Subjects: “…budget impact analysis…”
Get full text

Budget impact analysis of a multifaceted nurse-led intervention to reduce indwelling urinary catheter use in New South Wales Hospitals by Rod Ling, Michelle Giles, Andrew Searles

Subjects: “…Budget Impact Analysis…”
Get full text

RETRACTED: Opportunities of the method «Budget impact analysis» for performing pharmacoeconomic research by V. V. Ryazhenov, S. G. Gorokhova, N. D. Bunyatyan

Subjects: “…budget impact analysis…”
Get full text

Budget impact of the Walk With Ease program for knee osteoarthritis by Mahima T. Kumara, Rebecca J. Cleveland, Aleksandra M. Kostic, Serena E. Weisner, Kelli D. Allen, Yvonne M. Golightly, Heather Welch, Melissa Dale, Stephen P. Messier, David J. Hunter, Jeffrey N. Katz, Leigh F. Callahan, Elena Losina

Subjects: Get full text

Budget impact of vildagliptin by Orietta Zaniolo, Viola Sacchi, Lorenzo Pradelli

Subjects: Get full text

PHARMACOECONOMIC ANALYSIS OF DOCETAXEL IN THE ADJUVANT THERAPY OF BREAST CANCER by R. I. Yagudina, I. Yu. Zinchuk

Subjects: Get full text

CLINICAL AND ECONOMIC EVALUATION OF LACOSAMIDE IN PATIENTS WITH PARTIAL EPILEPSY by E. A. Pyadushkina, M. Yu. Frolov

Subjects: Get full text

Introduction of the telemonitoring device Turbo+ in the management of patients suffering from asthma in Italy: a budget impact analysis by Filippo Rumi, Michele Basile, Americo Cicchetti, Rosario Contiguglia, Antonella Pentassuglia, Alessandro Oliva, Gianenrico Senna, Marco Bonavia, Francesco Scarpelli, Marco Benvenuto

Subjects: Get full text

Budget impact analysis of the use of paricalcitol for the treatment of secondary hyperparathyroidism in chronic kidney disease by Valentina Lorenzoni, Giuseppe Turchetti

Subjects: “…budget impact analysis…”
Get full text

Budget Impact analysis of a new system of care in Parkinson’s disease patients by Chiara Bini, Francesco Saverio Mennini, Andrea Marcellusi, Martina Paoletti, Carlo Tomino

Subjects: Get full text

Evaluating the effect of a Russian rituximab biosimilar used to treat patients with rheumatoid arthritis on healthcare budgets by R. O. Dreval

Subjects: “…budget impact analysis…”
Get full text

HIV partner services in Kenya: a cost and budget impact analysis study by Peter Cherutich, Carey Farquhar, Beatrice Wamuti, Felix A. Otieno, Ann Ng’ang’a, Peter Maingi Mutiti, Paul Macharia, Betsy Sambai, David Bukusi, Carol Levin, for the aPS Study Group

Subjects: “…Budget impact analysis…”
Get full text

Budget impact analysis of the use of daclatasvir in Italy for the treatment of Hepatitis C Virus (HCV) genotype 3 patients by Umberto Restelli, Alfredo Alberti, Adriano Lazzarin, Marzia Bonfanti, Carmela Nappi, Davide Croce

Subjects: Get full text